Shimyn Slomovic

Shimyn Slomovic serves as the Senior Director and Head of Gene Therapy R&D at Fractyl Health since October 2023. Prior to this, Shimyn provided advisory services at Ascidian Therapeutics from August 2020 to October 2023, where responsibilities included leading molecular biology efforts and advancing gene therapy programs from discovery to clinical stages. Shimyn co-founded Dyno Therapeutics and headed biology initiatives, developing methodologies for AAV capsid engineering and overseeing lab operations. Previous experience includes a Research Scientist role at the Wyss Institute, focusing on HIV diagnostics, and postdoctoral fellowships at the Massachusetts Institute of Technology and Technion - Israel Institute of Technology, where significant contributions to pathogenic detection systems and RNA research were made. Shimyn holds a PhD in Molecular Biology and a BA in Molecular Biology from Technion - Israel Institute of Technology.